Resumption of Winthrop Pharma Senegal by MediS laboratories.

Apr 13 2017

-New development prospects are opening up for the Winthrop Pharma Senegal (WPS) company, its factory and its employees.-

Dakar, April 17,2017^th - MédiS and Sanofi today announced the purchase of Sanofi's shares in the WPS company by the MédiS group, which is now MédiS in Senegal. This new entity broadens the number of MédiS group production sites which until now included the MédiS laboratories in Tunisia, the NEAPOLIS PHARMA laboratories in Tunisia, the Inpha - MédiS laboratories in Algeria and the MédiS International laboratories in the Czech Republic.

The takeover of WPS offers undeniable assets to succeed in the development of MédiS in Africa:

Winthrop Pharma Senegal, a joint venture, was created in 1973 in Dakar and employs approximately 150 people. Its activity is dedicated to the manufacture and distribution of sterile ampoules, tablets and syrups for Sanofi in Senegal and sub-Saharan Africa.

« "The takeover of WPS will allow MédiS laboratories to develop internationally. MédiS in Senegal will allow us to increase our presence in Senegal on the one hand and in sub-Saharan Africa on the other hand. » said Mr. Lassaad BOUJBEL, Executive President of the MédiS group.

La reprise de la société WPS offre des atouts indéniables pour réussir le développement de MédiS en Afrique:

With the acquisition of a new base in Senegal.
With the expertise and professionalism of WPS employees.
With the expertise and professionalism of the Medis teams: R&D, Quality Assurance, Quality Control, Marketing ...
With the contribution of new products and services.
With the maintenance of the manufacture and distribution of Sanofi drugs.
With the acquisition of Winthrop Pharma Senegal products registered in French-speaking SubSaharan Africa.

«This partnership is a great opportunity for Sanofi in Senegal. Through a contract with MédiS in Senegal, Sanofi will continue to strengthen its presence in the country and in sub-Saharan Africa by maintaining local manufacturing and developing the distribution of Sanofi drugs». said Mr. Aboubacar.

Tio-Touré, General Manager of Sanofi Senegal.

Sanofi, through its subsidiary in Senegal, occupies the position of leader of the Senegalese pharmaceutical market and is closest to patients for several decades.

About MédiS

MédiS, the leading generic drug manufacturer in Tunisia and the first Tunisian multinational in the pharmaceutical industry, manufactures and markets quality medications in several therapeutic areas: cardiology, diabetes, neuropsychiatry, oncology, pain, allergies, gastrology, as well as a wide range of biosimilar medications for multiple sclerosis and infertility. MédiS has over 720 approved drugs worldwide, 480 of which are in Africa, and is present internationally with subsidiaries in Algeria and the Czech Republic.

Media Contact

Sanofi has been present in Senegal for decades and is the leading pharmaceutical company in Senegal. Sanofi in Senegal offers a comprehensive range of innovative and patient-centered therapeutic solutions.

Christiane Mbimbe :

Sanofi Africa Francophone Sub-Saharan

E-mail: christiane.mbimbe@sanofi.com

Nabil SAADAOUI- CEO MédiS

E-mail : n.saadaoui@medis.com.tn

Retour vers Communiqué